CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 353 of 865
Non-Antibody Products
Page 353 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| GS-39783 | A positive allosteric modulator of GABAB receptors; potentiates GABA-stimu… | 50 mg | 29482-50 | More Info |
| GS-441524 | An antiviral nucleoside analog; metabolized to an active triphosphate form… | 1 mg | 30469-1 | More Info |
| GS-441524 | An antiviral nucleoside analog; metabolized to an active triphosphate form… | 10 mg | 30469-10 | More Info |
| GS-441524 | An antiviral nucleoside analog; metabolized to an active triphosphate form… | 25 mg | 30469-25 | More Info |
| GS-441524 | An antiviral nucleoside analog; metabolized to an active triphosphate form… | 5 mg | 30469-5 | More Info |
| GS-621763 | An orally bioavailable prodrug form of GS-443902; reduces the cytopathic e… | 1 mg | 34125-1 | More Info |
| GS-621763 | An orally bioavailable prodrug form of GS-443902; reduces the cytopathic e… | 500 µg | 34125-500 | More Info |
| GS-704277 | An intermediate alanine metabolite of remdesivir | 1 mg | 9003569-1 | More Info |
| GS-704277 | An intermediate alanine metabolite of remdesivir | 500 µg | 9003569-500 | More Info |
| GS-7340 | A prodrug from of tenofovir; reduces HIV-1 viral replication in MT-2 cells… | 10 mg | 26214-10 | More Info |
| GS-7340 | A prodrug from of tenofovir; reduces HIV-1 viral replication in MT-2 cells… | 100 mg | 26214-100 | More Info |
| GS-7340 | A prodrug from of tenofovir; reduces HIV-1 viral replication in MT-2 cells… | 5 mg | 26214-5 | More Info |
| GS-7340 | A prodrug from of tenofovir; reduces HIV-1 viral replication in MT-2 cells… | 50 mg | 26214-50 | More Info |
| GS-9620 | An orally available TLR7 agonist (EC50 = 291 nM); stimulates a TLR7 immune… | 10 mg | 19628-10 | More Info |
| GS-9620 | An orally available TLR7 agonist (EC50 = 291 nM); stimulates a TLR7 immune… | 100 mg | 19628-100 | More Info |
| GS-9620 | An orally available TLR7 agonist (EC50 = 291 nM); stimulates a TLR7 immune… | 25 mg | 19628-25 | More Info |
| GS-9620 | An orally available TLR7 agonist (EC50 = 291 nM); stimulates a TLR7 immune… | 5 mg | 19628-5 | More Info |
| GS967 | A selective inhibitor of late INa that has been shown to suppress experime… | 100 mg | 18376-100 | More Info |
| GS967 | A selective inhibitor of late INa that has been shown to suppress experime… | 25 mg | 18376-25 | More Info |
| GS967 | A selective inhibitor of late INa that has been shown to suppress experime… | 50 mg | 18376-50 | More Info |
| GS-9973 | A potent Syk inhibitor (IC50 = 7.7 nM) that demonstrates 10-35-fold select… | 1 mg | 17653-1 | More Info |
| GS-9973 | A potent Syk inhibitor (IC50 = 7.7 nM) that demonstrates 10-35-fold select… | 10 mg | 17653-10 | More Info |
| GS-9973 | A potent Syk inhibitor (IC50 = 7.7 nM) that demonstrates 10-35-fold select… | 5 mg | 17653-5 | More Info |
| GS-9973 | A potent Syk inhibitor (IC50 = 7.7 nM) that demonstrates 10-35-fold select… | 50 mg | 17653-50 | More Info |
| GS-444217 | An AKS1 inhibitor (IC50 = 2.87 nM); selective for ASK1 over 442 additional… | 10 mg | 40757-10 | More Info |
| GS-444217 | An AKS1 inhibitor (IC50 = 2.87 nM); selective for ASK1 over 442 additional… | 25 mg | 40757-25 | More Info |
| GS-444217 | An AKS1 inhibitor (IC50 = 2.87 nM); selective for ASK1 over 442 additional… | 5 mg | 40757-5 | More Info |
| GS-444217 | An AKS1 inhibitor (IC50 = 2.87 nM); selective for ASK1 over 442 additional… | 50 mg | 40757-50 | More Info |
| GSA 10 | A SMO agonist that can promote the differentiation of multipotent mesenchy… | 10 mg | 16164-10 | More Info |
| GSA 10 | A SMO agonist that can promote the differentiation of multipotent mesenchy… | 25 mg | 16164-25 | More Info |
| GSA 10 | A SMO agonist that can promote the differentiation of multipotent mesenchy… | 5 mg | 16164-5 | More Info |
| GSA 10 | A SMO agonist that can promote the differentiation of multipotent mesenchy… | 50 mg | 16164-50 | More Info |
| GSK0660 | The first reported selective antagonist of PPARβ/δ (IC50 = 155… | 10 mg | 15272-10 | More Info |
| GSK0660 | The first reported selective antagonist of PPARβ/δ (IC50 = 155… | 25 mg | 15272-25 | More Info |
| GSK0660 | The first reported selective antagonist of PPARβ/δ (IC50 = 155… | 5 mg | 15272-5 | More Info |
| GSK0660 | The first reported selective antagonist of PPARβ/δ (IC50 = 155… | 50 mg | 15272-50 | More Info |
| GSK1059615 | A potent, reversible, ATP-competitive, thiazolidinedione inhibitor of PI3K… | 10 mg | 11569-10 | More Info |
| GSK1059615 | A potent, reversible, ATP-competitive, thiazolidinedione inhibitor of PI3K… | 25 mg | 11569-25 | More Info |
| GSK1059615 | A potent, reversible, ATP-competitive, thiazolidinedione inhibitor of PI3K… | 5 mg | 11569-5 | More Info |
| GSK1059615 | A potent, reversible, ATP-competitive, thiazolidinedione inhibitor of PI3K… | 50 mg | 11569-50 | More Info |
| GSK1070916 | A potent inhibitor of Aurora B and C (Kis = 0.38 and 1.5 nM, respectively)… | 1 mg | 22953-1 | More Info |
| GSK1070916 | A potent inhibitor of Aurora B and C (Kis = 0.38 and 1.5 nM, respectively)… | 10 mg | 22953-10 | More Info |
| GSK1070916 | A potent inhibitor of Aurora B and C (Kis = 0.38 and 1.5 nM, respectively)… | 25 mg | 22953-25 | More Info |
| GSK1070916 | A potent inhibitor of Aurora B and C (Kis = 0.38 and 1.5 nM, respectively)… | 5 mg | 22953-5 | More Info |
| GSK126 | A selective, SAM-competitive small molecule inhibitor of EZH2 methyltransf… | 1 mg | 15415-1 | More Info |
| GSK126 | A selective, SAM-competitive small molecule inhibitor of EZH2 methyltransf… | 10 mg | 15415-10 | More Info |
| GSK126 | A selective, SAM-competitive small molecule inhibitor of EZH2 methyltransf… | 5 mg | 15415-5 | More Info |
| GSK1292263 | A GPR119 agonist (EC50 = 43.9 nM in CHO-K1 cells expressing human GPR119);… | 10 mg | 26181-10 | More Info |
| GSK1292263 | A GPR119 agonist (EC50 = 43.9 nM in CHO-K1 cells expressing human GPR119);… | 25 mg | 26181-25 | More Info |
| GSK1292263 | A GPR119 agonist (EC50 = 43.9 nM in CHO-K1 cells expressing human GPR119);… | 5 mg | 26181-5 | More Info |
| GSK1292263 | A GPR119 agonist (EC50 = 43.9 nM in CHO-K1 cells expressing human GPR119);… | 50 mg | 26181-50 | More Info |
| GSK189254 | A histamine H3 receptor antagonist (Kis = 0.13, 0.68, and 1.74 nM for the… | 10 mg | 36705-10 | More Info |
| GSK189254 | A histamine H3 receptor antagonist (Kis = 0.13, 0.68, and 1.74 nM for the… | 25 mg | 36705-25 | More Info |
| GSK189254 | A histamine H3 receptor antagonist (Kis = 0.13, 0.68, and 1.74 nM for the… | 5 mg | 36705-5 | More Info |
| GSK1940029 | A stearoyl-CoA desaturase inhibitor; increases palmitate-induced phosphory… | 1 mg | 36704-1 | More Info |
| GSK1940029 | A stearoyl-CoA desaturase inhibitor; increases palmitate-induced phosphory… | 10 mg | 36704-10 | More Info |
| GSK1940029 | A stearoyl-CoA desaturase inhibitor; increases palmitate-induced phosphory… | 25 mg | 36704-25 | More Info |
| GSK1940029 | A stearoyl-CoA desaturase inhibitor; increases palmitate-induced phosphory… | 5 mg | 36704-5 | More Info |
| GSK2018682 | An S1P1 and S1P5 receptor agonist; selective for S1P1 and S1P5 over S1P2,… | 10 mg | 31437-10 | More Info |
| GSK2018682 | An S1P1 and S1P5 receptor agonist; selective for S1P1 and S1P5 over S1P2,… | 25 mg | 31437-25 | More Info |
| GSK2018682 | An S1P1 and S1P5 receptor agonist; selective for S1P1 and S1P5 over S1P2,… | 5 mg | 31437-5 | More Info |
| GSK2018682 | An S1P1 and S1P5 receptor agonist; selective for S1P1 and S1P5 over S1P2,… | 50 mg | 31437-50 | More Info |
| GSK2033 | An antagonist of LXRα and LXRβ (IC50s = 0.1 and 0.398 µM,… | 1 mg | 25443-1 | More Info |
| GSK2033 | An antagonist of LXRα and LXRβ (IC50s = 0.1 and 0.398 µM,… | 10 mg | 25443-10 | More Info |
| GSK2033 | An antagonist of LXRα and LXRβ (IC50s = 0.1 and 0.398 µM,… | 5 mg | 25443-5 | More Info |
| GSK2126458 | A potent inhibitor of PI3K isoforms (Kis = 19, 130, 24, and 60 pM for p110… | 1 mg | 17377-1 | More Info |
| GSK2126458 | A potent inhibitor of PI3K isoforms (Kis = 19, 130, 24, and 60 pM for p110… | 10 mg | 17377-10 | More Info |
| GSK2126458 | A potent inhibitor of PI3K isoforms (Kis = 19, 130, 24, and 60 pM for p110… | 5 mg | 17377-5 | More Info |
| GSK2126458 | A potent inhibitor of PI3K isoforms (Kis = 19, 130, 24, and 60 pM for p110… | 50 mg | 17377-50 | More Info |
| GSK2190915 | A selective inhibitor of human FLAP (IC50 = 2.9 nM); selective for FLAP ov… | 1 mg | 28600-1 | More Info |
| GSK2193874 | A potent, selective antagonist of TRPV4 channels, blocking the influx of c… | 1 mg | 17715-1 | More Info |
| GSK2193874 | A potent, selective antagonist of TRPV4 channels, blocking the influx of c… | 10 mg | 17715-10 | More Info |
| GSK2193874 | A potent, selective antagonist of TRPV4 channels, blocking the influx of c… | 25 mg | 17715-25 | More Info |
| GSK2193874 | A potent, selective antagonist of TRPV4 channels, blocking the influx of c… | 5 mg | 17715-5 | More Info |
| GSK2194069 | An inhibitor of fatty acid synthase (IC50 = 7.7 nM in an assay detecting r… | 1 mg | 20022-1 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile